Our Lady of the Lake Hospital
16
1
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
6.3%
1 terminated/withdrawn out of 16 trials
80.0%
-6.5% vs industry average
19%
3 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Body Composition Outcomes in MS Patients
Role: collaborator
Post-operative Pain Control-TAP Block Using Exparel vs. Marcaine for Hernia Repairs
Role: collaborator
Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients
Role: lead
Exercise Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
Role: lead
Determining the Necessity for Postoperative Antibiotics After Salivary Stent Placement
Role: lead
Inhalational Anesthesia vs TIVA in Endoscopic Tympanoplasty
Role: lead
Comparing Topical Tetracaine Drops to Topical Focal Phenol for Local Anesthesia During Intratympanic Steroid Injection
Role: lead
Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer
Role: collaborator
The Utility of Long-acting Local Anesthetic Agents in Reducing Post-operative Opioid Requirements Following Rhinoplasty
Role: lead
TIVA vs TXA in Sinus Surgery to Evaluate Operative Blood Loss and Surgical Field Quality
Role: lead
Our Lifestyles Our Lives
Role: collaborator
Post-Surgical Injection With Triamcinolone Versus Triamcinolone/Fluorouracil in Treatment of Keloids
Role: lead
Complete Decongestive Therapy on Head and Neck Lymphedema
Role: lead
Rapid Atrial Fibrillation Treatment Strategy
Role: lead
Lymphedema Treatment for Blunt Facial Trauma
Role: lead
Pupillometry for the Prediction of Neurologic Outcomes in Severe Traumatic Brain Injury
Role: lead
All 16 trials loaded